J.Safra Asset Management Corp

Position in ALNY — Alnylam Pharmaceuticals, Inc.

CIK 1535293 NEW YORK, NY

Position in ALNY

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$939,815

+$75,252 QoQ

Shares Held

3,122

+19.5% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#410

of 784 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

J.Safra Asset Management Corp holds $2,957,680 across 41 Biotechnology names. ALNY ranks #1 (31.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc. This page	3,122	$939,815
2	INSM	INSMED Inc	7,650	$815,643
3	PCVX	Vaxcyte, Inc.	12,564	$730,345
4	ASND	Ascendis Pharma A/S	121	$32,273
5	COGT	Cogent Biosciences, Inc.	695	$26,896
6	ARGX	Argenx SE	26	$24,122
7	TECH	BIO-TECHNE Corp	338	$23,879
8	MRNA	Moderna, Inc.	328	$22,969

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$939,815	3,122	+19.5%	Shares	Sole	2026-08-06
2026-03-31	$864,563	2,613	+59.4%	Shares	Sole	2026-05-04
2025-12-31	$651,748	1,639	+17.5%	Shares	Sole	2026-02-11
2025-09-30	$636,120	1,395	+3144.2%	Shares	Sole	2025-10-29
2025-06-30	$14,021	43	+4.9%	Shares	Sole	2025-10-29
2025-03-31	$11,070	41	+485.7%	Shares	Sole	2025-10-29
2024-12-31	$1,647	7	0.0%	Shares	Sole	2025-02-06
2024-09-30	$1,925	7	+250.0%	Shares	Sole	2024-11-13
2023-09-30	$354	2	0.0%	Shares	Sole	2023-11-13
2023-06-30	$379	2	0.0%	Shares	Sole	2023-08-04
2023-03-31	$400	2	0.0%	Shares	Sole	2023-05-12
2022-12-31	$475	2	—	Shares	Sole	2023-02-10
No filing history on record for this holder in this stock.